Phase 3 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with migraine (with or without aura) for at least 6 months before the screening visit, based on recognised international headache diagnosis guidelines.
- People who consistently fill in a daily headache diary on an electronic device for at least 23 out of 28 days during the screening period.
- People who, during that same 28-day screening period, have no more than 14 days with headaches, and at least 4 of those days are migraine days as recorded in the diary.
Who may not be able to join:
- People with a history or diagnosis of certain other headache types, such as chronic tension-type headache, cluster headache, hypnic headache, or specific less common migraine types including hemiplegic migraine or migraine with brainstem aura, among others (confirm with trial site for the full list).
- People with a history of moderate or severe head injury, or another neurological or serious medical condition that, in the doctor's opinion, is likely to affect how the brain and nervous system work.
- People with a current mental health condition that has not been managed or treated for at least 6 months before the screening visit, or people who have ever had a history of psychosis or mania.
- People with any other medical condition where treating that condition would need to take priority over treating migraine, or where the condition might interfere with taking part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Email contact via H. Lundbeck A/S, HQ_Medinfo@Lundbeck.com
Phone: +45 36301311
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change From Baseline in the Number of Monthly Migraine Days (MMDs) Averaged Over Weeks 1-12
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.